On December 16, 2015 NIH released its NIH-Wide Strategic Plan, Fiscal Years 2016-2020: Turning Discovery Into Health. The Endocrine Society provided input to the NIH during the strategic planning process and sent a letter to the Director of NIH, Francis Collins, MD, and NIH Principal Deputy Director, Lawrence Tabak, DDS, PhD. In our comments, the...
NIH Clarifies Instructions to Grantees on Incorporating Sex as a Biological Variable
In 2014, in response to requests by the Endocrine Society, the National Institutes of Health (NIH) announced that it would develop policies to require investigators to account for sex as a fundamental biological variable in NIH-supported preclinical research. The Endocrine Society wholeheartedly supports the goal of ensuring that sex is considered in studies funded by...
The Republican-led Congress and Democratic White House just closed out a surprisingly productive year in 2015, marked by the long-fought repeal of the Medicare physician payment system and passage of a $1.15 trillion spending bill that included a $2-billion increase for the National Institutes of Health (NIH) – two of the Endocrine Society’s top legislative...Congress Reaches Compromise on FY 2016 Funding; Provides $2 Billion for NIH
After much debate and negotiation, Congress reached a compromise on the fiscal year (FY) 2016 appropriations bill that will finalize the budgets for the National Institutes of Health (NIH) and other research agencies through September. The bill includes $32 billion for NIH (a $2 billion increase), the amount recommended by the Endocrine Society. The omnibus...
The Endocrine Society increasingly is called to contribute to policy discussions in the U.S. and globally concerning regulation of endocrine-disrupting chemicals (EDCs). The Society’s goal in reaching out to regulators, policymakers, and other stakeholders is to ensure that regulatory decisions involving EDCs incorporate relevant endocrine principles and are informed by modern endocrine science. In November...
As this item is posted, the fate of the fiscal year (FY) 2016 budget for the National Institutes of Health (NIH) remains uncertain. While Congress was able to reach a budget agreement in September that raises the amount of spending allowed and opens the door for an increase for NIH and other programs, Congress is...
During September and October, the Society participated in two important international meetings related to Endocrine Disrupting Chemicals (EDCs). The Society was the only scientific organization participating and, as such, it was able to share the Society’s latest Scientific Statement on EDCs and link health impacts to EDCs, and was seen as a trusted policy advisor....
NIH Funding Announcements of Interest to Endocrine Scientists
On September 14, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), in collaboration with the National Cancer Institute (NCI), published a series of RFAs (Requests for Applications) that are intended to stimulate multi-disciplinary research on developmental issues for individuals and families affected by differences or disorders of sex development (DSD),...
